Vor Biopharma Inc at Stifel Healthcare Conference Transcript
(audio in progress) we have Nathan Jorgensen, who is the Chief -- I'm Stephen Willey, one of the senior biotech analysts here at Stifel, and glad to have with us here for the next session Vor Biopharma.
With us and to my left, we have Nathan Jorgensen, who is the Chief Financial Officer. We have Tirtha Chakraborty, who is the Chief Scientific Officer. I think some of you may have seen that Robert Ang was scheduled to present here, but I believe he's been taken out.
So appreciate you guys making the trip. And we're going to have just kind of an informal discussion around the state of things that Vor. If anyone has a question, feel free to raise your hand. We'll try to get it asked and addressed.
Nathan, not sure if you want to make any kind of opening comments before we get into Q&A [in order].
I'll just say thank you for having us here, Steve. It's a pleasure to be back here at Stifel. And it's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
